Navigation Links
Dr. M. Fatih Yanik joins Intellimedix
Date:6/12/2013

ATLANTA, June 12, 2013 /PRNewswire-iReach/ -- Dr. M. Fatih Yanik has recently joined the team at Intellimedix and will oversee the company's new technology development efforts. Dr. Yanik is an associate professor in the Electrical Engineering department of MIT and heads the school's High-Throughput Neurotechnology Group. In 2011, he was awarded the most prestigious NIH award, the NIH Director's Pioneer Award, and is the youngest recipient in the history of this award. Dr. Yanik is also the first person ever to receive all of the top NIH awards:  the NIH Director's New Innovator Award, the NIH EUREKA Award, the NIH Transformative Research Award, and the NIH Director's Pioneer Award.

"Fatih Yanik is a pioneer in the development of technologies for regenerative neurobiology and development of innovative drug discovery models and platforms. Additionally, Dr. Yanik and his research team have developed a novel and groundbreaking method of creating induced pluripotent stem cells (iPSCs) using RNA-based technology that holds great promise for personalized neurobiology. Fatih brings a treasure trove of talent to Intellimedix," says Dr. Jeffrey Skolnick, Chief Scientist at Intellimedix.

"Intellimedix has a very dedicated and world-class team who is truly passionate about finding cures for epilepsy and other neurological disorders. I am truly excited to join them in this endeavor as we set out to improve the quality of life for many people," says Dr. Yanik.

Dr. Yanik will play a major role in developing novel technologies and guiding the research at Intellimedix's Cambridge, MA based lab.

About IntelliMedix:

IntelliMedix was founded in early 2012 with the purpose of developing and applying novel technologies to accelerate the discovery of new therapies for neurological diseases and creating new approaches for personalized medicine. They employ cutting-edge technology that includes gene sequencing, in silico screening, optogenetics, synthetic biology, and high-throughput in vivo and in vitro models. The company's current focus is on developing new treatments for Dravet Syndrome and other types of intractable epilepsy. For more information, please visit http://www.intellimedix.com

Media Contact:

Joanna Morrison Intellimedix, 770.399.9930, jmorrison@intellimedix.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE IntelliMedix
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
2. Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
3. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
4. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
5. David F. Harty Joins Systech International as Vice President
6. Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer
7. Ted Pacha Joins Pinnaclife as President of its Healthcare Distribution Division
8. Rittal Corp. Joins the HP ProActive Insight Architecture Alliance
9. Anthony Creed Joins DDSTUDIO As GM, Experience Design
10. IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board
11. American Society of Hematology joins European Hematology Association, Patient Groups in Issuing International Call to Action to Alleviate Drug Shortages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... http://www.rebound-solution.com/ ...
(Date:9/27/2017)... their devotion to personalized service, SMP Pharmacy Solutions announces their ... South Florida Business Journal,s 50 Fastest-Growing Companies, and listed for ... specialty pharmacy has found its niche.  To that end, the ... by SFBJ as the 2017 Power Leader in Health Care. ... award in October, Bardisa said of the three achievements, "It,s ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology:
(Date:10/13/2017)... IL (PRWEB) , ... October 13, 2017 , ... ... which established the certification process to promote standards of excellence for the field ... Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):